1-2 of 2
Natasha Galasso
Close
Sort by
Journal Articles

TP53 mutations identify high-risk events for peripheral T-cell lymphoma treated with CHOP-based chemotherapy

William T. Johnson, Nivetha Ganesan, Zachary D. Epstein-Peterson, Alison J. Moskowitz, Robert N. Stuver, Catherine R. Maccaro, Natasha Galasso, Tiffany Chang, Niloufer Khan, Umut Aypar, Natasha E. Lewis, Andrew D. Zelenetz, M. Lia Palomba, Matthew J. Matasar, Ariela Noy, Audrey M. Hamilton, Paul Hamlin, Philip C. Caron, David J. Straus, Andrew M. Intlekofer, Connie Lee Batlevi, Anita Kumar, Colette N. Owens, Craig S. Sauter, Lorenzo Falchi, Jennifer K. Lue, Santosha A. Vardhana, Gilles Salles, Ahmet Dogan, Nikolaus D. Schultz, Maria E. Arcila, Steven M. Horwitz
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5172–5186.
https://doi.org/10.1182/bloodadvances.2023009953
Published: 2023
Includes: Supplemental data
Journal Articles

T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma

Clinical Trials & Observations
Paola Ghione, Promie Faruque, Neha Mehta-Shah, Venkatraman Seshan, Neval Ozkaya, Shakthi Bhaskar, James Yeung, Michael A. Spinner, Matthew Lunning, Giorgio Inghirami, Alison Moskowitz, Natasha Galasso, Nivetha Ganesan, Carrie van der Weyden, Jia Ruan, H. Miles Prince, Judith Trotman, Ranjana Advani, Ahmet Dogan, Steven Horwitz
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4640–4647.
https://doi.org/10.1182/bloodadvances.2020002396
Published: 2020
Includes: Supplemental data